Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Kallyope Snags $66M in Series B to Continue Gut-Brain Axis Research February 21, 2018 Poor Mid-Stage Results Sink AbbVie’s Plans for Cancer Drug March 21, 2018 Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility February 7, 2018
